Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CTSV | O60911 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | CTSC | P53634 | 1/20 | 0.33 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3266074 | 0.81 | HCAR2 (0.31) | — | |
| SCHEMBL3273351 | 0.79 | — | — | |
| SCHEMBL3267149 | 0.78 | SMN1; SMN2 (0.40) | ALDH1A1TDP1 | |
| SCHEMBL5091907 | 0.77 | — | — | |
| SCHEMBL3273884 | 0.77 | — | — | |
| SCHEMBL8547070 | 0.77 | — | — | |
| SCHEMBL3271279 | 0.73 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL10354500 | 0.71 | MAPT (0.45) | MAPTALDH1A1TDP1CYP3A4CYP2C19 | |
| SCHEMBL3071497 | 0.70 | — | — | |
| SCHEMBL24519217 | 0.70 | MAPT (0.44) | MAPTALDH1A1TDP1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1517881-B1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2010-06-02 | — | — | EP | disclosed |
| US-7414064-B2 | 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2008-08-19 | — | — | US | disclosed |
| US-20070142445-A1 | 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2007-06-21 | — | — | US | disclosed |
| US-7192965-B2 | 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-20050245583-A1 | 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives | SYNGENTA CROP PROTECTION, INC. | 2005-11-03 | — | — | US | disclosed |
| EP-1517881-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | Syngenta Participations AG (CH) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004002943-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245583-A1 | 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives | DDT, RER1, SCN7A | MAPT 1819/4885ALDH1A1 3383/4885TDP1 4240/4885 |
| US-20070142445-A1 | 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives | DDT, RER1, SCN7A | MAPT 1819/4885ALDH1A1 3383/4885TDP1 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.